Bombay Bio-Research Centre Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.86 Cr
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -34.04%
- Profit Growth 99.68%
- Ebitda 98.82%
- Net Worth -1.34%
- Total Assets -3.12%
About Bombay Bio-Research Centre
Bombay Bio-Research Centre Private Limited (BBCPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 December 2011 and has a history of 13 years and one month. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.86 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shraddha Dhamankar, Nirmal Mulye, and Anilkumar Mulye serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74120MH2011PTC224950
-
Company No.
224950
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Dec 2011
-
Date of AGM
15 Jul 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Bombay Bio-Research Centre?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nirmal Mulye
|
Director | 20-Dec-2011 | Current |
Shraddha Dhamankar
|
Director | 14-Dec-2011 | Current |
| Anilkumar Mulye | Additional Director | 18-Sep-2024 | Current |
Financial Performance of Bombay Bio-Research Centre.
Bombay Bio-Research Centre Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 34.04% decrease. The company also saw a substantial improvement in profitability, with a 99.68% increase in profit. The company's net worth dipped by a decrease of 1.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bombay Bio-Research Centre?
In 2023, Bombay Bio-Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Thurs Organics Private LimitedShraddha Dhamankar is a mutual person
-
Nexgen Healthcare Private LimitedShraddha Dhamankar and Anilkumar Mulye are mutual person
-
Enem Nostrum Remedies Private LimitedShraddha Dhamankar, Nirmal Mulye and 1 more are mutual person
-
Nli Healthcare (India) Private Limited
Shraddha Dhamankar, Nirmal Mulye and 1 more are mutual person
-
Symmetrix Biotech Private LimitedShraddha Dhamankar and Nirmal Mulye are mutual person
-
Nostrum Technologies Private Limited
Shraddha Dhamankar, Nirmal Mulye and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bombay Bio-Research Centre?
Unlock and access historical data on people associated with Bombay Bio-Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bombay Bio-Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bombay Bio-Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
